Genome-wide association studies of antidepressant class response and treatment-resistant depression

被引:41
作者
Li, Qingqin S. [1 ]
Tian, Chao [2 ]
Hinds, David [2 ]
机构
[1] Janssen Res & Dev LLC, Titusville, NJ 08560 USA
[2] 23andMe Inc, Sunnyvale, CA USA
关键词
GENE-EXPRESSION; PHARMACOGENETICS; DISORDER;
D O I
10.1038/s41398-020-01035-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The "antidepressant efficacy" survey (AES) was deployed to > 50,000 23andMe, Inc. research participants to investigate the genetic basis of treatment-resistant depression (TRD) and non-treatment-resistant depression (NTRD). Genome-wide association studies (GWAS) were performed, including TRD vs. NTRD, selective serotonin reuptake inhibitor (SSRI) responders vs. non-responders, serotonin-norepinephrine reuptake inhibitor (SNRI) responders vs. non-responders, and norepinephrine-dopamine reuptake inhibitor responders vs. non-responders. Only the SSRI association reached the genome-wide significance threshold (p < 5 x 10(-8)): one genomic region in RNF219-AS1 (SNP rs4884091, p = 2.42 x 10(-8), OR = 1.21); this association was also observed in the meta-analysis (13,130 responders vs. 6,610 non-responders) of AES and an earlier "antidepressant efficacy and side effects" survey (AESES) cohort. Meta-analysis for SNRI response phenotype derived from AES and AESES (4030 responders vs. 3049 non-responders) identified another genomic region (lead SNP rs4955665, p = 1.62 x 10(-9), OR = 1.25) in an intronic region of MECOM passing the genome-wide significance threshold. Meta-analysis for the TRD phenotype (31,068 NTRD vs 5,714 TRD) identified one additional genomic region (lead SNP rs150245813, p = 8.07 x 10(-9), OR = 0.80) in 10p11.1 passing the genome-wide significance threshold. A stronger association for rs150245813 was observed in current study (p = 7.35 x 10(-7), OR = 0.79) than the previous study (p = 1.40 x 10(-3), OR = 0.81), and for rs4955665, a stronger association in previous study (p = 1.21 x 10(-6), OR = 1.27) than the current study (p = 2.64 x 10(-4), OR = 1.21). In total, three novel loci associated with SSRI or SNRI (responders vs. non-responders), and NTRD vs TRD were identified; gene level association and gene set enrichment analyses implicate enrichment of genes involved in immune process.
引用
收藏
页数:12
相关论文
共 48 条
[11]   Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci [J].
Eriksson, Nicholas ;
Tung, Joyce Y. ;
Kiefer, Amy K. ;
Hinds, David A. ;
Francke, Uta ;
Mountain, Joanna L. ;
Do, Chuong B. .
PLOS ONE, 2012, 7 (04)
[12]   Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits [J].
Eriksson, Nicholas ;
Macpherson, J. Michael ;
Tung, Joyce Y. ;
Hon, Lawrence S. ;
Naughton, Brian ;
Saxonov, Serge ;
Avey, Linda ;
Wojcicki, Anne ;
Pe'er, Itsik ;
Mountain, Joanna .
PLOS GENETICS, 2010, 6 (06) :1-20
[13]  
Ethical & Independent Review Services, 2015, I REV BOARD
[14]   New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation [J].
Fabbri, C. ;
Tansey, K. E. ;
Perlis, R. H. ;
Hauser, J. ;
Henigsberg, N. ;
Maier, W. ;
Mors, O. ;
Placentino, A. ;
Rietschel, M. ;
Souery, D. ;
Breen, G. ;
Curtis, C. ;
Sang-Hyuk, L. ;
Newhouse, S. ;
Patel, H. ;
Guipponi, M. ;
Perroud, N. ;
Bondolfi, G. ;
O'Donovan, M. ;
Lewis, G. ;
Biernacka, J. M. ;
Weinshilboum, R. M. ;
Farmer, A. ;
Aitchison, K. J. ;
Craig, I ;
McGuffin, P. ;
Uher, R. ;
Lewis, C. M. .
PHARMACOGENOMICS JOURNAL, 2018, 18 (03) :413-421
[15]   Diagnosis and definition of treatment-resistant depression [J].
Fava, M .
BIOLOGICAL PSYCHIATRY, 2003, 53 (08) :649-659
[16]   Gene expression elucidates functional impact of polygenic risk for schizophrenia [J].
Fromer, Menachem ;
Roussos, Panos ;
Sieberts, Solveig K. ;
Johnson, Jessica S. ;
Kavanagh, David H. ;
Perumal, Thanneer M. ;
Ruderfer, Douglas M. ;
Oh, Edwin C. ;
Topol, Aaron ;
Shah, Hardik R. ;
Klei, Lambertus L. ;
Kramer, Robin ;
Pinto, Dalila ;
Gumus, Zeynep H. ;
Cicek, A. Ercument ;
Dang, Kristen K. ;
Browne, Andrew ;
Lu, Cong ;
Xie, Lu ;
Readhead, Ben ;
Stahl, Eli A. ;
Xiao, Jianqiu ;
Parvizi, Mahsa ;
Hamamsy, Tymor ;
Fullard, John F. ;
Wang, Ying-Chih ;
Mahajan, Milind C. ;
Derry, Jonathan M. J. ;
Dudley, Joel T. ;
Hemby, Scott E. ;
Logsdon, Benjamin A. ;
Talbot, Konrad ;
Raj, Towfique ;
Bennett, David A. ;
De Jager, Philip L. ;
Zhu, Jun ;
Zhang, Bin ;
Sullivan, Patrick F. ;
Chess, Andrew ;
Purcell, Shaun M. ;
Shinobu, Leslie A. ;
Mangravite, Lara M. ;
Toyoshiba, Hiroyoshi ;
Gur, Raquel E. ;
Hahn, Chang-Gyu ;
Lewis, David A. ;
Haroutunian, Vahram ;
Peters, Mette A. ;
Lipska, Barbara K. ;
Buxbaum, Joseph D. .
NATURE NEUROSCIENCE, 2016, 19 (11) :1442-1453
[17]   Pharmacogenetics of antidepressant response: A polygenic approach [J].
Garcia-Gonzalez, Judit ;
Tansey, Katherine E. ;
Hauser, Joanna ;
Henigsberg, Neven ;
Maier, Wolfgang ;
Mors, Ole ;
Placentino, Anna ;
Rietschel, Marcella ;
Souery, Daniel ;
Zagar, Tina ;
Czerski, Piotr M. ;
Jerman, Borut ;
Buttenschon, Henriette N. ;
Schulze, Thomas G. ;
Zobel, Astrid ;
Farmer, Anne ;
Aitchison, Katherine J. ;
Craig, Ian ;
McGuffin, Peter ;
Giupponi, Michel ;
Perroud, Nader ;
Bondolfi, Guido ;
Evans, David ;
O'Donovan, Michael ;
Peters, Tim J. ;
Wendland, Jens R. ;
Lewis, Glyn ;
Kapur, Shitij ;
Perlis, Roy ;
Arolt, Volker ;
Domschke, Katharina ;
Breen, Gerome ;
Curtis, Charles ;
Sang-Hyuk, Lee ;
Kan, Carol ;
Newhouse, Stephen ;
Patel, Hamel ;
Baune, Bernhard T. ;
Uher, Rudolf ;
Lewis, Cathryn M. ;
Fabbri, Chiara .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 75 :128-134
[18]   A Genomewide Association Study of Citalopram Response in Major Depressive Disorder [J].
Garriock, Holly A. ;
Kraft, Jeffrey B. ;
Shyn, Stanley I. ;
Peters, Eric J. ;
Yokoyama, Jennifer S. ;
Jenkins, Gregory D. ;
Reinalda, Megan S. ;
Slager, Susan L. ;
McGrath, Patrick J. ;
Hamilton, Steven P. .
BIOLOGICAL PSYCHIATRY, 2010, 67 (02) :133-138
[19]  
Gilly A, 2018, METAANALYSIS QUANTIT
[20]  
Hodge RebeccaD., 2019, Nature, P384826